Immix Biopharma (IMMX) Treasury Shares (2022 - 2026)

Immix Biopharma has disclosed Treasury Shares across 5 years of filings, most recently posting $99963.0 for Q1 2026.

• Treasury Shares for Q1 2026 came in at $99963.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $99963.0 (changed 0.0% YoY), and the FY2025 annual result was $99963.0, changed 0.0% from the prior year.
• Treasury Shares came in at $99963.0 for Q1 2026 at Immix Biopharma, roughly flat from $99963.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $72363.0 in Q4 2022 to a low of -$72363.0 in Q4 2023.
• The 5-year median for Treasury Shares is $0.0 (2022), against an average of $0.0.
• Peak annual rise in Treasury Shares reached 78.62% in 2023, while the deepest fall reached 0.0% in 2023.
• Immix Biopharma's Treasury Shares stood at $99963.0 in 2022, then changed by 0.0% to $99963.0 in 2023, then changed by 0.0% to $99963.0 in 2024, then changed by 0.0% to $99963.0 in 2025, then changed by 0.0% to $99963.0 in 2026.
• The last three Treasury Shares figures came in at $99963.0 (Q1 2026), $99963.0 (Q4 2025), and $99963.0 (Q3 2025), per Business Quant data.